How to Stop Taking Adderall and Other Stimulants

Most people who want to stop taking Adderall have already tried. Of the 290+ clients we have worked with across 12 countries over 7 years, 98.4% had already tried and failed to stop before they came to us. With stimulants the attempts tend to look the same: a week off after a bad crash, a rule about only taking it on big days, half a pill instead of a whole one, a promise to stop after this quarter. Then a deadline arrives, or a pitch, or just a heavy, tired morning, and the bottle is in the drawer.

The usual explanation for those failures is a lack of willpower. That explanation is wrong in a specific way. The pill isn't only a habit. For many people it has become part of how they work. It supplies alertness, drive and the feeling that a dull task matters, and it does so on demand. Stopping takes that supply away from someone whose sleep, appetite and energy have usually been run down by the pill itself. So the decision to stop is made by a rested person on a calm day, and has to be carried out by a tired person facing a deadline. People are poor at predicting how differently they'll think in that second state¹. Deliberate control by the front of the brain is real, but it's the faculty most easily taken offline by stress, tiredness and short sleep^2-4.

Modern addiction research explains what is happening underneath. Koob and Volkow describe addiction as a cycle of three stages, each run by different brain systems: taking the drug and its reward, in which dopamine teaches the habit and turns it into routine; withdrawal and low mood, in which the reward system responds less and the brain's stress systems take a bigger role; and preoccupation, in which craving rises and the front of the brain can't hold it back⁵. Prescription stimulants have their own version of each stage. They raise dopamine and norepinephrine directly. Each dose is followed by a comedown. And the drug comes with a reason that sounds responsible: it's for the work.

The loop has five points, and each one can be worked on. The deadline can be planned for. The dose can be taken out of reach. The long night can be protected. The crash can be met with sleep, food and daylight rather than another pill. The last point, the next dose, is where people usually try to use willpower, and it's the weakest place to fight, because it comes when they are most tired.

Taken together, the research points to a different approach. Rebuild sleep, morning energy and regular meals first, so the pill has less to make up for. Then stop, on a plan agreed with your prescriber if you have one, and expect the first week or two to be hard. Then map the moments that used to mean a pill, remove what can be removed, and prepare a response for every deadline and every thought that argues for one. Last, work on the belief that your best work needs it. The rest of this paper explains each step.

For most people, stopping a stimulant doesn't put the body in danger. Stimulant withdrawal doesn't bring the seizures that alcohol withdrawal can. What it brings is a crash: in studies of people stopping amphetamine-type drugs, the first days were marked by more sleep, more eating and a cluster of symptoms of depression⁶. That low mood is the part to take seriously. And whether you should stop suddenly depends on who prescribed the pill, how much you take and what else you take with it.

2.1If you have a prescription

If a doctor prescribed your stimulant, talk to them before you change anything. There are three reasons. The first is the condition it was prescribed for. ADHD doesn't go away when the pill does, and a prescriber can help you work out which of your difficulties belong to the condition and which belong to the way the pill has been taken. The second is the plan. A prescriber can taper the dose over weeks rather than stop it in a day, which is what Waqas, a tech founder in New York who came to us for Adderall, chose with his specialist: “And so we actually designed a plan together to help me kind of taper off of it over the course of a few weeks.” The third is honesty. Prescribers can only adjust a prescription to what is really happening, including doses taken early, extra pills, or pills from somewhere else.

Taking more than prescribed is common enough that researchers have names for it. In a national survey of US adults, 6.6% had used a prescription stimulant in the past year, and of those who misused one, 11% had last got the pills from one or more doctors⁷. The same study found that people who misused more often, or had a use disorder, were more likely to get their pills from doctors or from dealers. A prescription isn't a guarantee that the use is working as medicine.

2.2If you take high doses, often, or with other drugs

The more you take and the more often, the harder the stop tends to be. Heavy use brings a deeper crash, more disturbed sleep and a lower mood, and the people who take the most are also the most likely to take something to come down. Many people who take stimulants without a prescription also drink and use other drugs: in a national survey of US college students, those who used prescription stimulants non-medically were more likely to report using alcohol, cigarettes, marijuana, ecstasy and cocaine⁸. If you use alcohol, sleeping pills or anxiety medication to sleep after a stimulant, the stop has two parts, and the second part may need a doctor. Some sedatives, including benzodiazepines, are dangerous to stop suddenly after regular use.

Crushing and snorting pills, or injecting them, is a different level of risk. A systematic review of 111 studies of non-medical stimulant use found that most of it is oral and causes no or minor medical effects, but that serious harm, including death, occurs in some people, particularly when the drug is taken by a route other than the mouth⁹. If this is how you take them, see a doctor before you stop, and tell them how you've been using.

2.3The low mood after stopping

The mood drop after a stimulant is real, and for some people it's severe. In an inpatient study of 56 people stopping methamphetamine, the drug most studied for amphetamine-type withdrawal, depressive symptoms were present at the start and had largely resolved within a week¹⁰. Most people's low lifts on that kind of timescale. But a week can be long when you feel flat, and a few people have thoughts of self-harm in that stretch. Those thoughts are a reason to get help that day, not to wait them out. In the US, call or text 988. In the UK and Ireland, Samaritans answer on 116 123. Anywhere, your local emergency number will help.

No medication has been shown to treat amphetamine withdrawal itself. A Cochrane review found four small randomized trials, with 125 participants between them, and concluded that no medication is effective for it¹¹. That doesn't mean a doctor can't help. A doctor can look after sleep, mood and anything else you take, and can tell the difference between a withdrawal low and a depression that needs treatment in its own right. Our program doesn't prescribe or recommend medication. It works alongside whatever medical care a person has.

Adderall raises the levels of dopamine and norepinephrine in the gaps between nerve cells. Dopamine is the brain's signal that something is worth doing and worth repeating. Norepinephrine is its alertness signal. Together they make dull work feel interesting, long tasks feel possible and fatigue feel distant. That is the medical effect in ADHD, and it's also the effect people without ADHD are reaching for.

3.1Two drugs, two ways in

There are two main families of prescription stimulant. Methylphenidate, sold as Ritalin and Concerta, works mainly by blocking the transporter, the pump that clears dopamine and norepinephrine back into the nerve cell after they are released. With the pump blocked, each natural release lasts longer and does more. Amphetamine, sold as Adderall (a mix of amphetamine salts), Vyvanse (lisdexamfetamine, which the body converts into dextroamphetamine) and dexamphetamine, does that and more. Sulzer's review describes amphetamines as an exception among addictive drugs: they get inside the nerve ending and release dopamine through reverse transport, so the pump runs backwards, and release no longer depends on the nerve cell firing¹². Heal and colleagues' review traces how amphetamine's range of actions explains both its value as a treatment and its potential for misuse¹³.

The effect is large even at ordinary doses. Volkow and colleagues used brain scans to measure how much of the dopamine transporter oral methylphenidate blocked in seven healthy adults. Two hours after the dose, 5 mg blocked 12% of the transporters, 10 mg blocked 40%, 20 mg blocked 54%, 40 mg blocked 72% and 60 mg blocked 74%. Half the transporters were blocked at about 0.25 mg per kilogram of body weight, and at the doses used in treatment, the authors concluded, more than half are likely to be blocked¹⁴. In a second study, oral methylphenidate at doses in the treatment range clearly raised the level of dopamine outside the nerve cells in healthy adults¹⁵.

3.2Why the speed matters

Whether a stimulant feels like a medicine or a high depends less on how much dopamine rises than on how fast. When methylphenidate was given into a vein, it reached the brain quickly, and the high people felt followed that fast rise; the high faded quickly even though the drug stayed bound in the brain for much longer¹⁶. In another study of intravenous methylphenidate, the intensity of the high rose with the amount of dopamine released, and people whose dopamine didn't rise felt no high at all¹⁷. Taken by mouth, the same drug takes about an hour to peak in the brain¹⁴, which is one reason most people taking it as prescribed don't feel euphoric.

This is why the way a pill is taken matters so much. Crushing and snorting a tablet, or taking an immediate-release pill instead of an extended-release one, makes the rise faster and the effect closer to a high. Immediate-release preparations are linked to more misuse and diversion than extended-release ones¹⁸. Lisdexamfetamine was designed the other way: it is inactive until the blood converts it to dextroamphetamine, which gives a lower peak, a slower rise and lower drug-liking scores than the same dose of immediate-release dextroamphetamine, with effects lasting at least 14 hours in adults¹⁹.

3.3What the extra dopamine does

Volkow and colleagues proposed that methylphenidate works by amplifying the brain's own dopamine signals, which respond to what's happening around you, and that this could make the task in front of you feel more important¹⁵. That is a helpful description of what people describe on the drug. The work hasn't changed. It just feels like it matters, and finishing it feels good. Berridge and Robinson's research separates wanting, the drive dopamine powers, from liking, the pleasure itself, and shows that drugs can grow the wanting far beyond the liking²⁰. With stimulants, what grows is often the wanting of a particular state: the focused, confident, unstoppable version of yourself at your desk.

Repeated, that state becomes a habit. Everitt and Robbins describe how drug use shifts over time from deliberate, goal-directed actions to habits set off by the situations in which they happened, and then to compulsion²¹. A pill taken at the same desk, with the same first coffee, before the same kind of task, is a habit in the making. The rest of the paper follows that habit from the brain into the working week.

For people without ADHD, the measured gain is small, and in some studies there is none. What the drugs reliably change is how the work feels: more motivating, more engaging and more worth doing. People on them tend to believe their thinking has improved. Controlled studies mostly don't find that it has, at least not by much.

4.1What the controlled studies measured

The most direct evidence comes from trials in which healthy adults take a stimulant on one day and a placebo on another, without knowing which is which, and do the same tests both times. Roberts and colleagues pooled 47 such studies in healthy adults who weren't sleep-deprived. Methylphenidate had an overall effect of 0.21 on a standard scale, where 0.2 counts as small and 0.5 as medium, driven by gains in recall (0.43), sustained attention (0.42) and inhibitory control (0.27). Modafinil had an overall effect of 0.12. Across ten studies of d-amphetamine, there were no effects²². The authors noted that the user perception that these drugs are effective cognitive enhancers isn't supported by the evidence so far.

An earlier meta-analysis of 48 studies with 1,409 participants, by Ilieva, Hook and Farah, reached a similar view. It found small but significant gains in inhibitory control and short-term memory for recent events, small and less certain gains in working memory, and a medium effect on memory over longer delays that was undermined by signs of publication bias. The authors concluded that the effect of amphetamine and methylphenidate on healthy cognition is probably modest overall, and that healthy users may be taking them for energy and motivation more than for thinking²³.

The gap between feeling and measurement has been tested directly with Adderall. Ilieva, Boland and Farah gave healthy young adults mixed amphetamine salts and a placebo in a double-blind crossover trial and measured 13 abilities, including memory, inhibitory control, creativity, intelligence and scholastic achievement. The drug didn't enhance any of them for the participants in general, although lower-ability participants may have improved on a few tasks. Yet the participants believed their performance was more enhanced by the active capsule than by the placebo²⁴. They felt sharper. On the tests, they weren't.

4.2More effort is not the same as better work

The newest evidence suggests the drugs may make complex work worse, not better. Bowman and colleagues gave 40 healthy adults methylphenidate (30 mg), dextroamphetamine (15 mg), modafinil (200 mg) and a placebo on four separate days, and set them a version of the knapsack problem, a puzzle used to stand in for the hard, many-sided decisions of everyday work. On the drugs, people spent longer on each problem and made more moves: about six more with methylphenidate and seven more with dextroamphetamine. But the value they got from each move fell under all three drugs, and the value of their final answers dropped. The chance of finding the best solution, about half, didn't change. Some of the best performers on placebo fell below average on a drug²⁵. The authors' summary is that the drugs raise motivation, but lower the quality of the effort that complex problems need.

This matches what many high performers say once they stop. The hours on the drug felt productive, and some of them were. But a share of that time went into reworking, reorganizing and polishing, and into the kind of absorbed busyness that feels like progress. Faraone and colleagues' systematic review found that although academic and work performance are the reasons most often given for non-medical use, there is little evidence that it improves academic performance in people without ADHD⁹.

4.3People with ADHD are a different case

None of this means stimulants don't work as a treatment. In adults with ADHD, they reduce symptoms substantially. In a four-week trial of 420 adults with ADHD, all three doses of lisdexamfetamine reduced symptoms far more than placebo, with improvements from the first week²⁶. In a trial of extended-release mixed amphetamine salts in 255 adults with ADHD, the drug controlled symptoms for up to 12 hours²⁷. For someone with ADHD, the question is not whether to use a stimulant but how, and that is a question for their prescriber. This paper is about use that has moved past that: more than prescribed, without a prescription, or for the lift rather than the condition.

Because for most people the pill isn't a break from being in control. It's a tool for it. People who misuse prescription stimulants mostly do it to work: to stay alert, to concentrate, to study⁷. The habit grows inside the parts of life where you are most disciplined, and it's reinforced every time it helps you meet a standard you care about. That is what makes it so hard to see as a problem and so hard to stop.

5.1Who takes them, and why

The best national picture comes from Compton and colleagues' analysis of the 2015 and 2016 US National Surveys on Drug Use and Health, which covered 102,000 adults. In an average year, 6.6% of adults, about 16 million people, used a prescription stimulant. Most took them without misusing them, but 5 million misused them, and 0.4 million had a prescription stimulant use disorder. Among those who misused them, the most common reason the last time was to stay alert or concentrate (56%), followed by studying (22%). Only 16% did it to get high, experiment or offset another drug. The pills most often came free from a friend or relative (57%)⁷.

Non-medical use is concentrated among people under pressure to perform. In a national survey of 10,904 US college students, 4.1% had used a prescription stimulant non-medically in the past year, but the rate ranged from zero to 25% between colleges, and it was higher at colleges with more competitive admission standards⁸. A meta-analysis of studies of college students put the rate of stimulant medication misuse at 17%, mostly for academic reasons, with pills most often coming from peers who had prescriptions²⁸. Wilens and colleagues' systematic review found that 16% to 29% of students with a stimulant prescription had been asked to give, sell or trade their medication¹⁸. The habit doesn't stay at university. In the Global Drug Survey, an international web survey of people without ADHD, the use of prescription and illegal stimulants and modafinil to perform better at work or study rose in all 15 countries studied between the 2015 and 2017 surveys, and the people who used stimulants and modafinil this way rated their effect on performance as the most beneficial²⁹.

5.2Why the habit takes hold

Four things make a stimulant habit grip capable people. The first is that the reward comes fast and is attached to something you value. The pill turns a task you were avoiding into one you can't stop doing, and finishing it feels good. That is exactly the kind of experience the dopamine system learns from²⁰. The second is the crash. As the dose wears off, you're tired, flat, irritable and hungry, and the fastest way out is another dose. Koob and Volkow describe this shift from taking a drug for the lift to taking it to escape the low as a core stage of addiction⁵.

The third is the short time horizon that pressure creates. When a deadline is tomorrow, the cost of tonight's dose, a poor night's sleep and a flat day after, is far away, and the benefit is right now. Bickel and colleagues describe this short horizon, together with an excessive value placed on one reward, as the core of what they call reinforcer pathology³⁰. The fourth is identity. The pill becomes tied to a version of yourself you like: the one who outworks everyone, never drops the ball and can't be caught out. Stopping can feel like agreeing to be less.

Stress ties these together. Under stress, the brain shifts away from deliberate, goal-directed control and toward habit³, and stress itself weakens the prefrontal functions that would otherwise hold a habit back². In people leaving treatment for cocaine, another stimulant, the craving set off by a personal stress script predicted a shorter time to relapse³¹. For someone whose habit started with deadlines, every hard week is a test of the habit, and the habit was built to pass it.

Waqas, the tech founder in New York, was taking Adderall two or three times a week before he started with us. Looking back, he said: “And there were definitely times where I was using way more than I should have.” Two or three times a week is almost a schedule, and a schedule usually means triggers tied to particular days, workloads and hours. Section 11 describes how those triggers are mapped.

Yes. Prescription stimulants can be addictive, though most people who misuse them don't become addicted. In the US national survey, about 5 million adults misused a prescription stimulant in a year, and about 400,000 had a prescription stimulant use disorder: 8.7% of the people who misused one, or roughly 1 in 11⁷. The more useful question for any one person is not whether the drug is addictive in general, but whether their own use has stopped being a choice they make freely.

6.1How the brain adapts

The brain responds to a drug that keeps its dopamine signals running by adjusting itself. One measurable form of that adjustment is in the transporter that methylphenidate blocks. Wang and colleagues scanned 18 adults with ADHD before and after a year of prescribed methylphenidate, and 11 adults who weren't treated. After a year of treatment, the adults with ADHD had 24% more dopamine transporters in the striatum, a deep brain region central to reward and habit. The untreated group hadn't changed³². More transporters means dopamine is cleared faster when the drug isn't there. The authors suggested this could reduce the effect of the same dose over time, which would look like tolerance, and could make symptoms worse when the drug wears off.

This finding comes from prescribed treatment at ordinary doses in people with ADHD, so it can't say exactly what happens in people who take larger or irregular doses without a prescription. But it shows that the brain does adapt to a stimulant over months. Other adaptations are well documented in heavier stimulant use. In people who had used methamphetamine, which belongs to the same amphetamine family, transporter levels were low and recovered with long abstinence, measured at under six months and again at 12 to 17 months without the drug³³. Koob and Volkow describe a wider version of the same adjustment across addictions: with repeated use, the reward system responds less to the drug and to ordinary rewards, and the brain's stress systems take a bigger role⁵. These changes are a large part of why the days and weeks after stopping feel flat. They also tend to recover, which Section 9 describes.

6.2Signs that use has become a problem

Most misuse is occasional. In the national survey, 68% of the adults who had misused a prescription stimulant in the past year hadn't done so in the past month, and only about 6% had done so on seven or more days in the past month⁷. Frequency on its own isn't the test, though. Someone who takes a pill only before big deadlines, but has started arranging their work around big deadlines, has a problem that a count of days won't show. These questions are more useful than a count:

• Do you take more, or more often, than you planned to?
• Have you tried to cut down or stop, and found you couldn't?
• Do you think about getting or taking it when you aren't taking it?
• Do you need more to get the same effect, or feel worse than before when it wears off?
• Has it cost you sleep, meals, money, relationships or your health, and do you keep taking it anyway?
• Do you get pills from more than one source, take a friend's, or run out of a prescription early?
• Do you take something else, such as alcohol or a sleeping pill, to come down from it?
• Do you believe you can't do your best work without it?

A yes to several of these doesn't make a diagnosis. Only a clinician can do that. But it does mean the use is no longer simply under your control, and that a plan will do more than another promise. The last question matters most for the people we work with. The belief that the work needs the pill is what keeps the habit going after every other reason has gone.

Adderall and the other stimulants shorten sleep and suppress appetite. Both effects follow directly from what the drug is meant to do: keep the brain alert and the body ready to act. In a trial of lisdexamfetamine in 420 adults with ADHD, the side effects reported included dry mouth, decreased appetite and insomnia²⁶. For someone taking extra doses, late doses or doses on top of coffee, the effect on sleep is larger, and the lost sleep is then what the next morning's dose is used to cover.

7.1How long a dose keeps working

Modern stimulants are built to last. In a trial of extended-release mixed amphetamine salts in 255 adults with ADHD, the drug improved symptoms for up to 12 hours after a morning dose²⁷. Lisdexamfetamine's effects last at least 14 hours in adults¹⁹. That is the point of these preparations for someone with ADHD: one morning dose covers the working day. It also means that a second dose, taken at 3 pm for a deadline, can still be working at 3 am. Caffeine adds to it. In a controlled study, 400 mg of caffeine, about the amount in four cups of coffee, disrupted sleep even when it was taken 6 hours before bed³⁴.

7.2The debt you can't feel

Short sleep doesn't stay in the night it happened. Van Dongen and colleagues kept 48 healthy adults in a sleep laboratory and restricted them to 8, 6 or 4 hours in bed a night for 14 days. Those on 6 or 4 hours built up steady, dose-dependent losses on every test of thinking. After two weeks, 6 hours or less a night had produced deficits equal to up to two nights without any sleep. Across all their conditions, lapses in attention rose in step with the hours each person had been awake beyond about 15.84 a day³⁵. The finding that matters most here is what people felt. Their ratings of sleepiness rose in the first days and then barely changed, even as their performance kept falling. The authors concluded that people were largely unaware of their growing deficits.

That is the mechanism behind the borrowed energy people describe. A pill on Monday makes Monday productive and Monday night short. Tuesday starts in debt, but it doesn't feel like much of a debt, because the brain is poor at noticing it. What Tuesday does feel is heavy, slow and flat, and the fastest fix for that is another pill. By Thursday the person is working on pills to cover a sleep debt the pills created, and the only sign is the sense that they can't get going without one. Short sleep touches the reward system too: one night without sleep reduced the availability of dopamine D2 and D3 receptors in the ventral striatum, a core part of the reward system³⁶. And the stress that comes with a deadline weakens the front of the brain's ability to hold back an urge². The debt makes the next dose both more appealing and harder to refuse.

7.3Appetite and meals

Loss of appetite is one of the most common side effects of stimulants, even at prescribed doses²⁶. Some people take the drug partly for it: in the national survey, about 4% of adults who misused a stimulant did so the last time to lose weight⁷. Skipped breakfasts and lunches leave a working day running on the drug alone, and when the dose wears off in the evening, hunger and tiredness arrive together. Regular meals are one of the first things the program puts back, before the stop, because a body that has been fed through the day has less of a crash to cover.

Stimulants put extra load on the heart: they raise heart rate and blood pressure. At prescribed doses, that load hasn't been linked to heart attacks or strokes in the short term, but over years of use it has been linked to a gradual rise in heart disease, especially high blood pressure. Psychosis, seeing or hearing things that aren't there or believing things that aren't true, is rare. But it happens, it is more common with amphetamine than with methylphenidate, and the risk rises steeply with the dose. Almost all of this evidence comes from prescribed use, so it probably understates the risk of high or irregular doses.

8.1The heart

The short-term picture is reassuring. A study of 443,198 US adults aged 25 to 64, half of them taking ADHD medication, found that current use was not linked to more heart attacks, sudden cardiac deaths or strokes than use in the past³⁷. A meta-analysis of trials found that methylphenidate raised heart rate and systolic blood pressure compared with placebo, in adults as well as children, although the risk of cardiac events in the trials was not significant³⁸.

The long-term picture is less reassuring. Zhang and colleagues used Swedish national registers to follow 278,027 people with ADHD aged 6 to 64, and compared 10,388 who developed cardiovascular disease with 51,672 matched people who didn't. The longer people had taken ADHD medication, the higher their odds of cardiovascular disease, rising to 1.27 times the odds of people who hadn't taken it after three to five years. Each extra year of use was linked to 4% higher odds, with a larger rise of about 8% a year over the first three years. The strongest links were with high blood pressure and arterial disease³⁹.

Two cautions apply in opposite directions. The people in these studies were taking the drug as prescribed, at doses their doctors chose, usually with their blood pressure checked. Someone taking extra pills, late pills or pills on top of energy drinks is putting a larger load on the same system, and these studies don't measure that. On the other hand, the rise in risk is modest for any one person, and the studies show associations, not proof that the drug caused the disease. Anyone with chest pain, a racing or uneven heartbeat, or fainting while taking a stimulant should get medical help straight away.

8.2Psychosis and mania

New psychosis after starting a stimulant is uncommon. Moran and colleagues followed 221,846 adolescents and young adults aged 13 to 25 who started methylphenidate or amphetamine for ADHD. There were 343 episodes of new psychosis, about 1 in 660 patients, and the risk with amphetamine was 1.65 times the risk with methylphenidate⁴⁰. In a later study of 1,374 people aged 16 to 35 admitted to hospital with a first episode of psychosis or mania, taking a prescription amphetamine in the past month was linked to 2.68 times the odds, and doses above 30 mg a day of dextroamphetamine or its equivalent to 5.28 times the odds. Methylphenidate in the past month was not linked to raised odds⁴¹.

The dose finding matters most for people who take more than prescribed. A dose above 30 mg a day is within the range some adults are prescribed, and well within the range people reach when they take extra pills to get through a deadline. Sleep loss, which heavy use brings, makes it worse. Early signs to take seriously include hearing or seeing things others don't, feeling watched or followed, suddenly believing something unusual with complete certainty, or days of very little sleep with racing energy and ideas. Any of these is a reason to stop taking the drug and get medical help the same day.

The worst of stimulant withdrawal usually lasts a week to ten days. In a study of people stopping methamphetamine, which has been studied far more than prescription stimulants, symptoms peaked within 24 hours of the last dose and fell to near normal by the end of the first week. That acute phase was marked by more sleeping, more eating and a cluster of symptoms of depression. A milder subacute phase lasted at least two more weeks⁶. Craving lasts longer than the rest, which is why a plan that only covers the first week isn't enough.

9.1The first days

The first days after stopping are the crash, stretched out. Most people sleep a lot, feel heavy and slow, eat more and feel flat or low. In Zorick and colleagues' study of 56 people stopping methamphetamine on an inpatient ward, depressive symptoms and symptoms of psychosis present at the start had largely resolved within a week¹⁰. People coming off prescription stimulants at ordinary doses usually have a milder version of this, but the shape is similar. A week of low energy is expected, and it is easier to get through when it was expected.

9.2The weeks and months after

Craving behaves differently from the other symptoms. In Zorick's study, the craving people reported didn't fall significantly until the second week, and it was still present, at a lower level, at five weeks¹⁰. Craving set off by triggers can go the other way for a while. Wang and colleagues compared people who had stopped methamphetamine for six days, two weeks, a month, three months, six months and a year. The craving they reported in general fell with time. But the craving set off by reminders of the drug rose until three months, and then fell at six months and a year. Their decision-making and mood improved the longer they had been off the drug⁴². Researchers call this rise the incubation of craving.

For someone stopping prescription stimulants, the practical meaning is simple. The first week is about energy and mood, and the second and third months are about triggers. A deadline in month two can bring a stronger urge than anything in the first week, at a time when the person feels well and least expects it. The program's trigger work runs from Day 31 to Day 60 for that reason.

9.3Is there a medicine for it?

No medication has been shown to work for amphetamine withdrawal¹¹, and the review of treatments for stimulant use disorder by Ronsley and colleagues found insufficient evidence to support any medication for it either⁴³. What helps most is predictable: sleep, food, daylight, movement and time. A doctor can still help with sleep, mood and anything else a person is taking, and should be seen if the low mood is deep or doesn't lift.

Focus and energy take longer to return than mood, and they return gradually. Waqas described it a month after stopping: “Definitely don't have the exact same level of focus or energy as I did before, but I think that's going to come back. And I think this is way healthier for me and way more sustainable in the long term.” That gap is real, and expecting it is part of not treating it as a reason to start again. Section 10 covers what fills it.

You get focus and energy back by rebuilding what the pill was covering for. For most people that means enough sleep at regular times, daylight in the morning, movement, regular meals, and a working day designed so that focus is easier: fewer interruptions, the hard work in protected blocks and a plan for the dull tasks. None of these works as fast as a pill. Together they give steadier energy without the crash, and they don't stop working when the bottle is empty.

10.1Sleep first

Sleep is the biggest single source of the energy and focus people try to buy with a pill, because short sleep removes both and hides the fact that it has done so³⁵. The executive functions people want from a stimulant, planning, self-control and holding information in mind, are the first to suffer from lack of sleep, stress and poor physical health, and they improve when those improve⁴. The program puts sleep, daylight and the body clock in place in the first week, two weeks before the stop.

10.2Movement, food and daylight

Exercise gives a small, real lift. A meta-analysis of 79 studies found that a single session of exercise improved performance on tests of thinking, during and after the session, with a small overall effect⁴⁴. That's similar in size to the effect of methylphenidate on healthy adults reported in Section 4, and it comes with better sleep and mood rather than worse. Regular meals keep energy level through the day, and morning daylight helps set the body clock that controls when you feel alert and when you feel sleepy.

10.3Design the work, not just the worker

Much of what a stimulant does at work is make a badly designed day bearable: one with no protected time, constant interruptions and dull tasks left until the pressure forces them. Changing the situation works better than trying harder within it. Duckworth and colleagues' review of self-control strategies found that strategies applied early, such as choosing or changing the situation, are generally more effective than resisting a temptation once it arrives⁴⁵. The same is true of focus. A phone in another room, a closed inbox and a fixed block for the hardest task each remove a demand on attention that the pill used to cover. Deciding in advance exactly when and where a task will start, an if-then plan, raises the odds that it happens⁴⁶.

10.4Training the capacities directly

Some of the capacities people take stimulants for can be trained. Diamond's review describes executive functions as trainable, with gains that tend to be specific to what is practiced, and that come from demanding activities practiced regularly and with increasing difficulty⁴. The program includes memory training and strategy-game training in its first month, and asks each client to take up a demanding new pursuit. These are not substitutes for sleep, and they don't work in days. Their job is to give the person repeated, direct evidence that they can concentrate hard without a pill.

The urge to take a stimulant is usually set off by work: a deadline, a pitch or board meeting, a task that has been put off for days, a tired start to the day, or simply sitting down at the desk where the pill is usually taken. Feelings set it off too, most often tiredness, pressure and the fear of falling behind. People, places and things play a part: a colleague who shares, a hotel room before a presentation, the bottle in the desk drawer. Each of these can be mapped, and each one mapped can be planned for.

11.1How triggers form

A trigger is something the brain has learned to link with the drug. Every pill taken at the same desk, at the same time of day, before the same kind of task, strengthens that link, until the situation sets off the urge on its own. Everitt and Robbins describe how drug use moves from deliberate action to habit through exactly this process, as control shifts from goal-directed brain systems to habit systems set off by the situation²¹. The habit doesn't need the person to want the pill. It only needs the situation.

Stress makes triggers stronger. Under stress, people shift from deliberate, goal-directed choices toward habits³. In people being treated for cocaine dependence, craving set off by a personal stress story predicted a shorter time to relapse³¹. Kwako and colleagues proposed that addiction should be assessed across three areas: how strongly the person responds to the drug and its triggers, negative emotion, and executive function⁴⁸. A deadline hits all three at once: it is the situation the pill is linked to, it brings stress, and it comes with the tiredness that weakens control.

11.2What to do with each trigger

Triggers fall into four groups, and each group gets a different response. Some can be removed: the pills themselves, the refill reminders, the contact who sells them. Some can be avoided or changed: where the hardest work happens, or whether the first coffee is at the same desk. Some can be positioned for: the deadline that is coming whatever happens can be met with a protected night and work planned back from the due date. And some, the thoughts and feelings, can't be removed and have to be planned for, with a response decided in advance. Duckworth and colleagues found that removing and changing triggers, which work early, generally work better than resisting an urge already under way⁴⁵. Quinn and colleagues found that for strong habits, watching for the trigger and stopping the action, which they call vigilant monitoring, was the strategy that worked⁴⁹.

The thoughts deserve their own plan. “Just this once.” “This deadline is different.” “I'll stop after this quarter.” “Everyone in my team takes something.” Trying not to have such thoughts tends to bring them back more often⁵⁰. What works better is to recognize them, test them against the evidence, and have a prepared answer. An if-then plan, written in advance and specific to the trigger, gives that answer a place to land: if it's the night before a pitch and I think about a pill, then I close the laptop at 11 and go to bed⁴⁶.

Urges themselves pass. Bowen and Marlatt taught people who smoked to notice an urge and watch it rise and fall without acting on it, an approach often called urge surfing. It didn't reduce the urges themselves, but it weakened the link between urges and smoking⁵¹. That study was of smokers, not stimulant users, and we use it for the mechanism it describes. For someone stopping stimulants, the urge usually arrives as a thought about the work, and the same skill applies: notice it, name it, let it pass, and go back to the plan.

Treat it as one event, and go back to your plan the next day. Write down what happened in the hours before: the deadline, the night's sleep, what you told yourself. Find the trigger your plan missed and add a response for it. What you tell yourself about the pill matters more than the pill itself. If you decide it proves you've failed, the rest of the week tends to follow it.

12.1One pill is not a relapse

Researchers distinguish a lapse, a single use after stopping, from a relapse, a return to the old pattern. What connects them is often how the lapse is explained. Curry, Marlatt and Gordon studied people who had stopped smoking and then smoked again. Those who blamed the lapse on something fixed and personal, such as a lack of willpower, and who felt guilty and helpless about it, were more likely to go on to a full relapse. The authors called this reaction the abstinence violation effect⁵². Witkiewitz and Marlatt describe relapse as a process that unfolds over time, in which a lapse is a point where the outcome can still go either way⁵³. Across studies of people stopping alcohol and tobacco, the relapse curve has the same shape: losses are steepest soon after stopping and slow down as time without the drug builds up⁵⁴. Every week held makes the next one more likely.

Pilots are trained to go around when an approach isn't right, and nobody thinks of it as a crash. It's a planned move with a procedure. A lapse can be handled the same way. The habit research supports this: in Lally and colleagues' study of how new habits form, missing a single occasion didn't materially affect how automatic the new behavior became⁵⁵. One pill after a month off doesn't erase the month. Confidence matters for what happens next. Bandura found that direct experience of succeeding at something is the most dependable source of belief that you can do it⁴⁷, and a lapse that is analyzed and answered with a better plan leaves that experience intact.

The Behavior Control System is the same 90-day program for every habit, applied to the loop beneath each person's stimulant use. Days 1 to 30, brain chemistry restabilization, rebuild what the pill has been covering for: sleep, the body clock, daylight, exercise, meals, stress and a structured working day. The client stops taking stimulants on Day 15, after two weeks of that work, or on the dates their prescriber sets. Days 31 to 60, impulse control, work on the moment a pill actually happens: every trigger is mapped, the pills and the sources are removed, and each trigger left gets a prepared, rehearsed response, including the deadlines and the thoughts that argue for one. Days 61 to 90, identity rewiring, work on identity: the belief that good work needs a pill, and the work culture and pressures that still push toward one. Six months of aftercare follow. It asks for about thirty minutes of focused work a day: a short lesson each morning, a brief log each night, and a set of daily practices, which the program calls north stars, built into the routine the person already has.

13.1Before Day 1

Every program starts with a Root-Cause Diagnostic: an application describing the habits involved and what has already been tried, followed by a thirty-minute, one-on-one conversation with our team. For stimulants it has two jobs. The first is safety: it asks which stimulant, at what dose, how often, by what route, whether it is prescribed and what else the person takes to come down, and anyone with a prescription is asked to involve their prescriber (Section 2). The second is to identify the loop beneath the use: what the pill does for the person, the earliest recurring trigger, the conditions that make it likely, why earlier attempts broke down and what is missing for change to hold. Two people who both take Adderall before deadlines rarely have the same loop. One takes it to start the day after a short night; another only before presentations; a third takes it to keep up with a team where everyone does. The structure of the diagnostic parallels the three areas the Addictions Neuroclinical Assessment proposes: the urge set off by triggers, negative emotion and executive function⁴⁸. It is not a clinical assessment and takes no medical measurements.

A preparatory phase follows before Day 1 and doesn't count toward the 90 days. It separates the decision to stop from the start. The client sets out in concrete terms the life they are building and what the pills have cost it, makes a commitment to someone who matters to them, chooses a start date that marks a real boundary in their life, and proves to themselves that they can hold one full day of control. The choice of start date rests on the fresh start effect: temporal landmarks such as the start of a week, a month or a meaningful date were followed by increases in aspirational behavior⁵⁶. The day of control rests on Bandura's finding that direct experience of succeeding is the most dependable source of belief that one can do it⁴⁷. A commitment that is recorded and made to another person holds better than a private one⁵⁷.

13.2Why the order matters for stimulants

The order follows from the research in Sections 2 to 12. Sleep, daylight, movement and meals come first, because a stimulant is mostly used to cover their absence, and stopping it before they are in place leaves the person facing the crash with nothing underneath. The stop comes on Day 15, after two weeks of that work, so that the first days without the pill land on a body that is already sleeping and eating better. The trigger work comes in the second month, when the acute withdrawal is over⁶ but craving set off by triggers may still be growing⁴². Identity comes last, because the belief that good work needs a pill is the slowest part to change, and a new belief about yourself needs weeks of evidence behind it to be believed.

Identity matters more for stimulants than for most habits, because the drug is so often tied to a professional self-image. Oyserman and colleagues found that people act on an identity when it feels congruent with who they are and the situation they're in, and that this shapes what they see as possible⁵⁹. For someone who has come to see themselves as the person who outworks everyone, stopping has to include a new account of how that person does good work. The third phase builds it, and rehearses it against the high-pressure days most likely to test it. Mental rehearsal of a task improves later performance⁶⁰.

Replacement is the last step because a habit that did a job leaves a gap when it stops, and a gap left empty tends to be filled by whatever is most available. A replacement placed at the same time and in the same setting as the old habit can take over its context⁵⁸. Lally and colleagues found that a new daily behavior took a median of 66 days to reach 95% of its peak automaticity, with wide variation between people⁵⁵. By Day 90 the replacement has been in place long enough to start running on its own.

13.3In our client's words

One of our clients who came to us for Adderall has described his experience on the record. Waqas, a tech founder in New York, was taking it two or three times a week, and sometimes more: “And there were definitely times where I was using way more than I should have.” He and his specialist planned a gradual stop rather than a sudden one: “And so we actually designed a plan together to help me kind of taper off of it over the course of a few weeks.” When he recorded his interview, he said: “And it's been I think 31, 32 days since the last time I took it and I'm feeling great.” His words are shared with consent. They are one person's experience, at one point in time, and not evidence of what will happen for anyone else.

Phalanx Labs has worked with 290+ clients across 12 countries over 7 years. Of those clients, 98.4% had already tried and failed to stop before they came to us. Our success rate is 97%, defined as the share of clients who ran the program and stayed off the habit through the program and the six months of aftercare that follow it. That rate covers all of our clients and all of the habits they came with. We don't publish a separate rate for stimulants. Because the definition matters as much as the number, we set out below what each figure counts, how it is known and what it doesn't establish.

14.1How outcomes are tracked

Throughout the program, the client keeps a nightly log and completes a weekly progress update. These are written records of what happened, what was difficult and what was handled; they are not scored instruments. At the end of each of the first two phases the client has a progress call with our team, the first around Day 28 and the second after Day 60. During aftercare we follow up with clients on whether they have stayed off the habit. A client counts as a success when they have run the program and stayed off the habit through the program and the full six months of aftercare.

14.2What our figures don't show

• Self-report. Whether a client has stayed off stimulants is known from what the client tells us, not from urine or blood testing.
• Selection. Clients choose to apply, are accepted after a diagnostic in which we decline people we can't help, and are counted only if they ran the program. People who decide to work with us may differ in motivation or circumstance from people who don't.
• No comparison group. We can't say how many of the same people would have stopped through another route, such as working with their prescriber, treatment or simply time, over the same period.
• Time window. The success rate covers the program and six months of aftercare. It doesn't describe what happens after that, and the research in Section 9 shows that craving set off by triggers can last for months.
• All habits together. The rate is across every habit our clients bring. We don't report a rate for stimulants alone, and a single rate doesn't predict the outcome for any one person.
• Prescriptions. Where a client's stop follows a prescriber's plan, the outcome reflects both, and we can't separate the two.

14.3What the research in this paper doesn't show

The studies cited here have their own limits. Much of the evidence on withdrawal and craving comes from people stopping methamphetamine, often in inpatient settings^{6, 10, 42}. Prescription stimulants are close relatives, but people misusing them at ordinary doses are likely to have a milder version of the same course, and the timings may differ. Most of the evidence on the heart, psychosis and tolerance comes from people taking stimulants as prescribed for ADHD^{32, 39, 41}, so it may understate the risks of misuse at higher doses. The studies of cognitive enhancement are mostly short, laboratory studies in young, healthy adults^{22, 25}, and real working life is longer and more varied. Some of the mechanism we rely on comes from people who smoked rather than took stimulants, such as the research on urge surfing and on how a lapse is explained^{51, 52}, and we say so where we cite it. The national survey figures are from the US in 2015 and 2016⁷.

Other approaches have stronger trial evidence than ours. For people with cocaine or amphetamine addiction, a network meta-analysis of 50 randomized trials with 6,942 participants found that contingency management, in which people earn rewards for drug-free urine tests, combined with the community reinforcement approach was the only psychosocial treatment that increased the number of people abstinent at the end of treatment compared with usual care⁶¹. A review of systematic reviews found sufficient evidence to support contingency management for stimulant use disorder⁴³. Our method hasn't been tested in a randomized or controlled trial, its outcomes haven't been assessed independently, and it hasn't been published in a peer-reviewed journal. The research supports the reasoning behind each element. It doesn't show that the combination works, or how much each element contributes. The figures in Table 6 are our evidence for the combination, with the limits stated above. A controlled evaluation would need independent outcome assessment, a comparison condition and follow-up beyond six months. We would welcome one.

See a doctor or your prescriber before you stop if you have a prescription, if you take high doses most days, if you take stimulants other than by mouth, or if you take alcohol, sleeping pills or anxiety medication to come down. Get help straight away for chest pain, a racing or uneven heartbeat, fainting, seeing or hearing things that aren't there, days without sleep with racing thoughts, or thoughts of hurting yourself.

15.1When to see a doctor

• You have a prescription and want to change or stop it. Your prescriber plans the change with you, and can look again at the condition it was treating.
• You take high doses, take them most days, or crush, snort or inject them.
• You take alcohol, sleeping pills, benzodiazepines or other sedatives to come down. Some sedatives are dangerous to stop suddenly.
• You have a heart condition, high blood pressure, or a history of psychosis, mania or bipolar disorder.
• Your low mood after stopping is deep, or hasn't lifted after a couple of weeks.
• You think you may have ADHD and have never been assessed. Stopping a misused stimulant doesn't rule out treatment that's right for you.

15.2When to get help straight away

Call your local emergency number, or go to an emergency department, for chest pain, a racing or uneven heartbeat, or fainting; for seeing or hearing things that aren't there, or feeling sure you're being watched or followed; or for days of very little sleep with racing energy and ideas. If you have thoughts of hurting yourself, in the US call or text 988; in the UK and Ireland, call Samaritans on 116 123; anywhere else, call your local emergency number.

15.3What this program is not

The Behavior Control System is a structured behavior program. It is not therapy, clinical care or medical treatment, and it doesn't diagnose or treat ADHD or any other condition. It doesn't prescribe, change or stop medication, and it doesn't recommend that anyone stop a prescribed medicine without their prescriber. Where a client has a prescription, the program works alongside their prescriber and the stop follows the prescriber's plan. It isn't suitable as the only support for someone with severe dependence, psychosis, or a risk of harming themselves, who needs medical care first. Our team will say so in the diagnostic if it isn't the right fit.

This paper is general information, written to help someone understand how stimulant habits work and what stopping involves. It isn't medical advice for any one person. If you take a stimulant, the people best placed to advise you on your own health are your prescriber and your doctor.